ASEPCO Opens New California Facility
The new site will provide employees with more space, enhanced R&D facilities, and a fully functional sanitary products training center.
ASEPCO, a Watson-Marlow Fluid Technology Group bioprocessing applications manufacturing company, announced the opening of its new facility in Milpitas, CA, for expanded research and warehouse space.
The new site will provide employees with more space, enhanced R&D facilities, and a fully functional sanitary products training center, according to a Sept. 23, 2019 press release.
“We are delighted to be moving into our new expanded facility,” said Bill Mandel, president of ASEPCO, in the press release. “ASEPCO is committed to providing the highest quality bioprocessing valves. This move will enable us to enhance the services we offer and with our new state-of-the-art R&D facilities, to continue to develop the best products for all our customers’ biotechnology and pharmaceutical applications.”
Source: ASEPCO
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
